Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Hinge Health, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-53.0% vs price
Base Case (Median)
-22.2% vs price
Bull Case (75th pct.)
3.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $126.94 | 30.0% | Medium (25%) |
| Graham Number | $15.87 | -83.7% | Low (10%) |
| EV/FCF | $76.01 | -22.2% | Medium (20%) |
Based on 3 out of 7 methods, HNGE appears fairly valued at the current price of $97.67. The base case fair value of $76.01 implies 22.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.